Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

KROS

Keros Therapeutics (KROS)

Keros Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KROS
DateTimeSourceHeadlineSymbolCompany
07/03/202508:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
01/03/202509:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
01/03/202509:00GlobeNewswire Inc.Keros Therapeutics Announces Participation at Upcoming Healthcare ConferencesNASDAQ:KROSKeros Therapeutics Inc
27/02/202508:17Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KROSKeros Therapeutics Inc
27/02/202508:10Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:KROSKeros Therapeutics Inc
27/02/202508:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
27/02/202508:01GlobeNewswire Inc.Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:KROSKeros Therapeutics Inc
20/02/202508:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
20/02/202508:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
20/02/202508:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
31/01/202500:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
31/01/202500:00GlobeNewswire Inc.Keros Therapeutics to Present at the Guggenheim SMID Cap Biotech ConferenceNASDAQ:KROSKeros Therapeutics Inc
25/01/202508:15Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:KROSKeros Therapeutics Inc
22/01/202500:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
22/01/202500:00GlobeNewswire Inc.Keros Therapeutics Announces Effectiveness of Global License Agreement with Takeda to Advance ElriterceptNASDAQ:KROSKeros Therapeutics Inc
15/01/202522:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
15/01/202522:30GlobeNewswire Inc.Keros Therapeutics Announces Additional Update on the Phase 2 TROPOS TrialNASDAQ:KROSKeros Therapeutics Inc
11/01/202500:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
12/12/202422:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
12/12/202422:00GlobeNewswire Inc.Keros Therapeutics Announces Update on the Phase 2 TROPOS TrialNASDAQ:KROSKeros Therapeutics Inc
10/12/202411:30GlobeNewswire Inc.Keros Therapeutics Presents Clinical Data from its Elritercept Program at the 66th American Society of Hematology Annual Meeting and ExpositionNASDAQ:KROSKeros Therapeutics Inc
03/12/202423:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
03/12/202423:00GlobeNewswire Inc.Keros Therapeutics Announces Global License Agreement with Takeda to Advance ElriterceptNASDAQ:KROSKeros Therapeutics Inc
27/11/202400:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
27/11/202400:00GlobeNewswire Inc.Keros Therapeutics Announces Participation at Upcoming Healthcare ConferencesNASDAQ:KROSKeros Therapeutics Inc
13/11/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
09/11/202408:18Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
07/11/202408:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KROSKeros Therapeutics Inc
07/11/202408:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
07/11/202400:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:KROS